natgillin/translations-raw huggingface dataset:
Such disturbances have only been reported in very few cases after initiation of repaglinide treatment.
Takvi učinci zabilježeni su u samo nekoliko slučajeva na početku liječenja repaglinidom.
This may be due to progression of the severity of the diabetes or to diminished responsiveness to the medicinal product.
Razlog može biti progresija težine šećerne bolesti ili slabiji odgovor na lijek.
• Steroids (anabolic steroids and corticosteroids - used for anemia or to treat inflammation).
- Steroide (anaboličke steroide i kortikosteroide - za liječenje anemije ili za liječenje upale).
Repaglinide is rapidly absorbed from the gastrointestinal tract, which leads to a rapid increase in the plasma concentration of the active substance.
Repaglinid se brzo apsorbira iz gastrointestinalnog trakta, što dovodi do brzog povećanja koncentracije djelatne tvari u plazmi.
Repaglinide was detected in the milk of animals.
Repaglinid se izlučuje u mlijeko životinja.
Repaglinide should be used with caution or be avoided in patients receiving medicinal products which influence repaglinide metabolism (see section 4.5).
Repaglinid treba primjenjivati s oprezom ili izbjegavati u bolesnika koji uzimaju lijekove koji utječu na metabolizam repaglinida (vidjeti dio 4.5).
What Enyglid is and what it is used for
Što je Enyglid i za što se koristi
Other medicines and Enyglid
Drugi lijekovi i Enyglid
Based on in vitro data, repaglinide appears to be a substrate for active hepatic uptake (organic anion transporting protein OATP1B1).
Prema podacima in vitro, čini se da je repaglinid supstrat za aktivno preuzimanje u jetri (organski anionski transportni protein OATP1B1).
30 tablets 60 tablets 90 tablets 120 tablets 180 tablets 270 tablets 360 tablets
30 tableta 60 tableta 90 tableta 120 tableta 180 tableta 270 tableta 360 tableta
• Salicylates (e.g. aspirin).
- Salicilate (npr. aspirin).
• if you have a severe liver disease.
- ako imate tešku bolest jetre.
The most frequently reported adverse reactions are changes in blood glucose levels, i.e. hypoglycaemia.
Najčešće prijavljivane nuspojave su promjene razine glukoze u krvi, odnosno hipoglikemija.
Less than 1% of repaglinide is recovered in faeces.
Manje od 1% repaglinida izlučuje se fecesom.
In addition to the usual self-monitoring by the patient of blood and/or urinary glucose, the patient's blood glucose must be monitored periodically by the physician to determine the minimum effective dose for the patient.
Osim uobičajene samokontrole glukoze u krvi i/ili urinu, liječnik mora redovito provjeravati razinu glukoze u krvi bolesnika kako bi mogao odrediti minimalnu djelotvornu dozu za bolesnika.
Tell people you have diabetes and that if you pass out (become unconscious) due to a hypo, they must turn you on your side and get medical help straight away.
Recite ljudima da imate šećernu bolest i da Vas, ako se zbog hipoglikemije onesvijestite, obavezno okrenu na bok i odmah zatraže liječničku pomoć.
Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces.
Šećerna bolest tipa 2 je bolest kod koje gušterača ne stvara dovoljno inzulina za regulaciju razine šećera u krvi ili kada tijelo ne reagira normalno na inzulin koji stvara.
- Hypersensitivity to repaglinide or to any of the excipients listed in section 6.1.
- Preosjetljivost na repaglinid ili neku od pomoćnih tvari navedenih u dijelu 6.1.
As hypoglycaemia in this study was avoided through increased calorie intake, a relative overdose may result in an exaggerated glucose lowering effect with development of hypoglycaemic symptoms (dizziness, sweating, tremor, headache etc.).
Budući da je pojava hipoglikemije u ovom ispitivanju izbjegnuta povećanim unosom kalorija, relativno predoziranje može dovesti do pretjeranog snižavanja razine glukoze u krvi uz pojavu simptoma hipoglikemije (omaglica, znojenje, tremor, glavobolja itd.).
In debilitated or malnourished patients the initial and maintenance dosage should be conservative and careful dose titration is required to avoid hypoglycaemic reactions.
U oslabljenih ili pothranjenih bolesnika, početna doza lijeka i doza održavanja zahtijevaju oprezniji pristup pa je neophodna pažljiva titracija doze kako bi se izbjegle hipoglikemijske reakcije.
Allergy is very rare (may affect up to 1 in 10,000 people).
Alergija se javlja vrlo rijetko (mogu se pojaviti u manje od 1 na 10 000 osoba).
Hypoglycaemic reactions are generally mild/moderate but may occasionally develop into hypoglycaemic unconsciousness or coma.
Reakcije hipoglikemije općenito su blage/umjerene, ali ponekad mogu uzrokovati nesvjesticu ili komu.
Combination with Neutral Protamine Hagedorn (NPH) insulin or thiazolidinediones
Kombinacija s Neutralnim Protamin Hagedorn (NPH) inzulinom ili tiazolidindionima
Most cases were mild and transient, and very few patients discontinued treatment due to increased liver enzymes.
Većina slučajeva bila je slabog intenziteta i prolazna te je svega nekoliko bolesnika prekinulo liječenje zbog porasta jetrenih enzima.
Doses are usually taken within 15 minutes of the meal but time may vary from immediately preceding the meal to as long as 30 minutes before the meal (i.e. preprandially 2, 3, or 4 meals a day).
Doze se uobičajeno uzimaju unutar 15 minuta do obroka, ali vrijeme uzimanja može varirati od neposredno prije obroka do 30 minuta prije obroka (tj. preprandijalno 2, 3 ili 4 obroka dnevno).
Data from animal studies investigating effects on embryofetal and offspring development as well as excretion in milk is described in section 5.3.
Podaci o učincima na embriofetalni razvoj i razvoj mladunčadi te izlučivanju u majčino mlijeko dobiveni u ispitivanjima na životinjama opisani su u dijelu 5.3.
The warning signs of too high blood sugar appear gradually.
Znakovi koji upozoravaju na visoku razinu šećera u krvi se javljaju postupno.
What you need to know before you take Enyglid 3.
Što morate znati prije nego počnete uzimati Enyglid 3.
Glycosylated haemoglobin levels are also of value in monitoring the patient's response to therapy.
Razina glikoziliranog hemoglobina je također bitna u praćenju odgovora bolesnika na liječenje.
The maximum recommended daily dose is 16 mg.
Maksimalna preporučena dnevna doza je 16 mg.
If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take Enyglid.
Ako uzimate gemfibrozil (koristi se za snižavanje povišene razine masnoća u krvi) ne smijete uzimati
- Severe hepatic function disorder.
- Teški poremećaji funkcije jetre.
Blister pack (OPA/Alu/PVC-Alu): 30, 60, 90, 120, 180, 270 and 360 tablets in the box.
Blister pakiranje (OPA/Al/PVC-Al): 30, 60, 90, 120, 180, 270 i 360 tableta u kutiji.
Periodic monitoring is necessary to detect inadequate lowering of blood glucose at the recommended maximum dose level (i.e. primary failure) and to detect loss of adequate blood-glucose lowering response after an initial period of effectiveness (i.e. secondary failure).
Periodična kontrola je neophodna kako bi se utvrdilo nezadovoljavajuće sniženje glukoze u krvi pri primjeni maksimalne preporučene doze lijeka (tj. primarno zatajivanje) te da bi se otkrio gubitak odgovora odnosno odgovarajućeg snižavanja razine glukoze u krvi nakon početnoga razdoblja učinkovitosti lijeka (tj. sekundarno zatajivanje).
When repaglinide is used together with other medicinal products that are mainly secreted by the bile, like repaglinide, any potential interaction should be considered.
Kad se repaglinid primjenjuje zajedno s drugim lijekovima koji se uglavnom izlučuju putem žuči, kao i repaglinid, treba uzeti u obzir mogućnost pojave interakcija.
If patients are transferred from another oral hypoglycaemic medicinal product, the recommended starting dose is 1 mg.
Ako su bolesnici prethodno bili liječeni drugim oralnim antidijabetikom, preporučena početna doza je 1 mg.
• Clarithromycin, trimethoprim, rifampicin (antibiotic medicines).
- Klaritromicin, trimetoprim, rifampicin (antibiotici).
• The normal starting dose is 0.5 mg before each main meal.
- Uobičajena početna doza je 0,5 mg prije svakog glavnog obroka.
When symptoms of hypoglycaemia have disappeared or when blood sugar levels are stabilised continue repaglinide treatment.
Kada simptomi hipoglikemije nestanu ili Vam se stabilizira razina šećera u krvi, nastavite liječenje repaglinidom.
One epidemiological study suggested an increased risk of acute coronary syndrome in repaglinide treated patients as compared to sulfonylurea treated patients (see sections 4.4 and 4.8).
U jednom epidemiološkom ispitivanju primijećen je povećan rizik razvoja akutnog koronarnog sindroma u bolesnika liječenih repaglinidom u usporedbi s bolesnicima liječenih sulfonilurejom (vidjeti dijelove 4.4 i 4.8).
Your blood sugar may get too high (hyperglycaemia).
Razina šećera u krvi može postati previsoka (hiperglikemija).
Clinical study results have shown that repaglinide is optimally dosed in relation to main meals (preprandial dosing).
Rezultati kliničkih ispitivanja pokazuju da se optimalno doziranje repaglinida postiže ako se uzima prije glavnih obroka (preprandijalno doziranje).
In this case, the dosage of metformin should be maintained and repaglinide administered concomitantly.
U tom slučaju potrebno je nastaviti s propisanom dozom metformina, a repaglinid davati istodobno.
In type 2 diabetic patients, the insulinotropic response to a meal occurred within 30 minutes after an oral dose of repaglinide.
U bolesnika sa šećernom bolešću tipa 2, inzulinotropni odgovor na obrok pojavio se unutar 30 minuta nakon oralne doze repaglinida.
If your blood sugar is low or you feel a hypo coming on eat glucose tablets or a high sugar snack or drink, then rest.
Ako je razina šećera u krvi niska ili ako osjetite da počinje hipoglikemija uzmite tabletu s glukozom, međuobrok ili napitak bogat šećerom te se odmorite.
Should these symptoms occur, adequate action should be taken to correct the low blood glucose (oral carbohydrates).
Ako se ovi simptomi pojave, potrebno je poduzeti odgovarajuće mjere kako bi se ispravila niska razina glukoze u krvi (peroralna primjena ugljikohidrata).
Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.
Liječenje je potrebno započeti kao dodatak dijeti i tjelovježbi, kako bi se smanjila razina glukoze u krvi vezana uz obroke.
Symptoms such as swelling, difficulty in breathing, rapid heartbeat, feeling dizzy and sweating could be signs of anaphylactic reaction.
Simptomi kao što su oticanje, otežano disanje, ubrzani otkucaji srca, omaglica i znojenje mogu biti znakovi anafilaktičke reakcije.
The use of repaglinide might be associated with an increased incidence of acute coronary syndrome (e.g. myocardial infarction), see sections 4.8 and 5.1.
Primjena repaglinida može biti povezana s povećanom incidencijom akutnog koronarnog sindroma (primjerice, infarktom miokarda), vidjeti dijelove 4.8 i 5.1.
Cardiovascular disease
Kardiovaskularna bolest
This phenomenon is known as secondary failure, to distinguish it from primary failure, where the medicinal product is ineffective in an individual patient when first given.
Ta pojava se naziva sekundarno zatajivanje, za razliku od primarnoga zatajivanja kada je lijek u pojedinih bolesnika neučinkovit već pri prvoj primjeni.
This resulted in a blood glucose-lowering effect throughout the meal period.
Ovo je rezultiralo sniženjem razine glukoze u krvi tijekom razdoblja obroka.
Boxes of 30, 60, 90, 120, 180, 270 or 360 tablets in blisters are available.
Dostupne su kutije s 30, 60, 90, 120, 180, 270 ili 360 tableta u blisterima.
• Thiazides (diuretics or ‘water pills').
- Tiazide (diuretici ili 'tablete za izmokravanje').
If you take too many tablets, your blood sugar may become too low, leading to a hypo.
Ako uzmete previše tableta, može doći do prevelikog pada razine šećera u krvi, što vodi u hipoglikemiju.
• Ciclosporin (used to suppress the immune system).
- Ciklosporin (za potiskivanje odgovora imunološkog sustava).
Do not use this medicine after the expiry date which is stated on the blister and outer carton.
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na blisteru i vanjskom pakiranju.
Based on the experience with repaglinide and with other hypoglycaemic medicinal products the following adverse reactions have been seen: Frequencies are defined as: - Common (1/100 to <1/10) - Uncommon (1/1,000 to <1/100) - Rare (1/10,000 to <1/1,000) - Very rare (<1/10,000) - Not known (cannot be estimated from the available data)
- Često (1/100 do <1/10) - Manje često (1/1000 do <1/100) - Rijetko (1/10 000 do <1/1000) - Vrlo rijetko (<1/10 000) - Nepoznato (ne može se procijeniti iz dostupnih podataka)
β-blocking medicinal products may mask the symptoms of hypoglycaemia.
Beta-blokatori mogu prikriti simptome hipoglikemije.
• Itraconazole, ketokonazole (antifungal medicines).
- Itrakonazol, ketokonazol (lijekovi protiv gljivica).
Your doctor will work out your dose.
Vaš liječnik će odrediti koja Vam doza najbolje odgovara.
Rifampicin, a potent inducer of CYP3A4, but also CYP2C8, acts both as an inducer and inhibitor of the metabolism of repaglinide.
Rifampicin, snažni induktor CYP3A4, ali i CYP2C8, djeluje i kao induktor i kao inhibitor metabolizma repaglinida.
The warning signs of a hypo may come on suddenly and can include: cold sweat, cool pale skin, headache, rapid heart beat, feeling sick, feeling very hungry, temporary changes in vision, drowsiness, unusual tiredness and weakness, nervousness or tremor, feeling anxious, feeling confused, difficulty in concentrating.
Znakovi koji upozoravaju na hipoglikemiju mogu nastupiti iznenada i mogu obuhvaćati: hladan znoj, hladnu blijedu kožu, glavobolju, ubrzane otkucaje srca, mučninu, osjećaj jake gladi, privremene promjene vida, omamljenost, neuobičajen umor i slabost, nervozu ili nevoljno drhtanje, osjećaj tjeskobe, osjećaj smetenosti, poteškoće s koncentracijom.
There are no studies of repaglinide in pregnant women.
Nisu provedena ispitivanja repaglinida u trudnica.
This lack of pharmacodynamic effect was observed with a sub-therapeutic dose of repaglinide.
Izostanak farmakodinamičkog učinka opažen je pri primjenama supterapijskih doza repaglinida.
- Concomitant use of gemfibrozil (see section 4.5).
- Istodobna primjena gemfibrozila (vidjeti dio 4.5).
The recommended maximum starting dose of patients transferred to repaglinide is 1 mg given before main meals.
Preporučena maksimalna početna doza u bolesnika koji su prešli na repaglinid je 1 mg prije glavnih obroka.
However, no exact dosage relationship exists between repaglinide and the other oral hypoglycaemic medicinal products.
Međutim, ne postoji izravna veza u doziranju repaglinida i drugih oralnih antidijabetika.
Repaglinide pharmacokinetics are characterised by low volume of distribution, 30 L (consistent with distribution into intracellular fluid) and is highly bound to plasma proteins in humans (greater than
Farmakokinetika repaglinida karakterizirana je malim volumenom distribucije, 30 l (što je sukladno s distribucijom u unutarstaničnoj tekućini) i u velikom se postotku veže za proteine plazme u ljudi (više od 98%).
It cannot be excluded that other inducers, e.g. phenytoin, carbamazepine, phenobarbital, St John's wort, may have a similar effect.
Ne može se isključiti da ostali induktori, primjerice fenitoin, karbamazepin, fenobarbital, gospina trava mogu imati sličan učinak.
Refraction disorder*
Poremećaj refrakcije*
• Deferasirox (used to reduce chronic iron overload)
- Deferasiroks (za snižavanje prekomjernog dugotrajnog nakupljanja željeza).
Alcohol can change the ability of Enyglid to reduce the blood sugar.
Alkohol može promjeniti učinkovitost Enyglida u snižavanju razine šećera u krvi.
OTHER SPECIAL WARNINGS, IF NECESSARY
DRUGO(A) POSEBNO(A) UPOZORENJE(A), AKO JE POTREBNO
Concomitant use of rifampicin and repaglinide might therefore induce a need for repaglinide dose adjustment which should be based on carefully monitored blood glucose concentrations at both initiation of rifampicin treatment (acute inhibition), following dosing (mixed inhibition and induction), withdrawal (induction alone) and up to approximately two weeks after withdrawal of rifampicin where the inductive effect of rifampicin is no longer present.
Istodobna primjena rifampicina i repaglinida stoga može zahtijevati prilagodbu doze repaglinida, što treba činiti na osnovi pomnog praćenja koncentracije glukoze u krvi pri uvođenju terapije rifampicinom (akutna inhibicija), pri daljnjem doziranju (miješana indukcija i inhibicija), pri prestanku terapije (indukcija) te do približno dva tjedna nakon prestanka uzimanja rifampicina kada inducirajući učinak rifampicina više nije prisutan.
If you stop taking Enyglid
Ako prestanete uzimati Enyglid
Doses are usually taken within 15 minutes of the meal, but the time may vary from immediately preceding the meal to as long as 30 minutes before the meal.
Doze se obično uzimaju unutar 15 minuta prije obroka, iako vrijeme uzimanja može varirati od neposredno prije obroka do najviše 30 minuta prije obroka.
At such times, it may be necessary to discontinue repaglinide and treat with insulin on a temporary basis.
U takvim slučajevima možda će biti potrebno prekinuti uzimanje repaglinida te privremeno uvesti terapiju inzulinom.
When a patient stabilised on any oral hypoglycaemic medicinal product is exposed to stress such as fever, trauma, infection or surgery, a loss of glycaemic control may occur.
Kada je bolesnik, u kojega se stanje stabiliziralo primjenom bilo kojeg oralnog antidijabetika, izložen stresu kao što je vrućica, trauma, infekcija ili operativni zahvat, može doći do poremećaja regulacije glikemije.
You can take Enyglid with metformin, another medicine for diabetes, if your doctor prescribes it.
Enyglid možete uzimati s metforminom, drugim lijekom protiv šećerne bolesti, ako ga liječnik propiše.
Repaglinide should only be prescribed if poor blood glucose control and symptoms of diabetes persist despite adequate attempts at dieting, exercise and weight reduction.
Repaglinid treba propisivati samo kada loša regulacija glukoze u krvi i simptomi šećerne bolesti traju usprkos odgovarajućoj dijeti, tjelovježbi i smanjenju tjelesne težine.
A high interindividual variability (60%) in repaglinide plasma concentrations has been detected in the clinical trials.
U kliničkim ispitivanjima uočena je visoka interindividualna varijabilnost (60%) u koncentraciji repaglinida u plazmi.
• Octreotide (used to treat cancer).
- Oktreotid (za liječenje karcinoma).
Pharmaco-therapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excl. insulins, ATC code: A10BX02
Farmakoterapijska skupina: lijekovi za liječenje šećerne bolesti, drugi lijekovi za snižavanje razine glukoze u krvi, osim inzulina, ATK oznaka: A10BX02
If you get a hypo (low blood sugar)
Ako dobijete hipoglikemiju (niska razina šećera u krvi)
Repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise.
Repaglinid je indiciran u odraslih sa šećernom bolešću tipa 2 u kojih se hiperglikemija više ne može zadovoljavajuće regulirati dijetom, smanjenjem tjelesne težine i tjelovježbom.
The blood glucose-lowering effect of oral hypoglycaemic medicinal products decreases in many patients over time.
Učinak oralnih antidijabetika na snižavanje razine glukoze u krvi u mnogih bolesnika se s vremenom smanjuje.
Repaglinide was shown not to be teratogenic in animal studies.
Ispitivanjima na životinjama su pokazala da repaglinid nije teratogen.
Skin and subcutaneous tissue disorders
Poremećaji kože i potkožnog tkiva Preosjetljivost*
More severe hypoglycaemia with seizure, loss of consciousness or coma should be treated with intravenous glucose.
Tešku hipoglikemiju uz napadaje, gubitak svijesti ili komu potrebno je liječiti glukozom primijenjenom intravenski.
The elevated insulin levels did not persist beyond the time of the meal challenge.
Razine inzulina nisu ostale povećane nakon što je proteklo razdoblje obroka.
Allergy
Alergija
Enyglid has been shown to lower the blood sugar, which helps to prevent complications from your diabetes.
Enyglid snižava razinu šećera u krvi i time pomaže u sprečavanju komplikacija šećerne bolesti.
The following substances may reduce the hypoglycaemic effect of repaglinide: Oral contraceptives, rifampicin, barbiturates, carbamazepine, thiazides, corticosteroids, danazol, thyroid hormones and sympathomimetics.
Hipoglikemijski učinak repaglinida mogu smanjiti ovi lijekovi: oralni kontraceptivi, rifampicin, barbiturati, karbamazepin, tiazidi, kortikosteroidi, danazol, hormoni štitnjače i simpatomimetici.
Eight percent of one dose of repaglinide is excreted through the kidneys and total plasma clearance of the product is decreased in patients with renal impairment.
Osam posto pojedinačne doze repaglinida izlučuje se putem bubrega, a ukupni plazmatski klirens lijeka smanjen je u bolesnika s oštećenjem funkcije bubrega.
Repaglinide metabolites are excreted primarily via the bile.
Metaboliti repaglinida primarno se izlučuju putem žuči.
V. Holjevca 20/E 10450 Jastrebarsko Croatia
Holjevca 20/E, 10450 Jastrebarsko, Hrvatska
The following substances may enhance and/or prolong the hypoglycaemic effect of repaglinide: Gemfibrozil, clarithromycin, itraconazole, ketoconazole, trimethoprim, ciclosporin, deferasirox, clopidogrel, other antidiabetic substances, monoamine oxidase inhibitors (MAOI), non selective beta blocking substances, angiotensin converting enzyme (ACE)-inhibitors, salicylates, NSAIDs, octreotide, alcohol, and anabolic steroids.
Sljedeće tvari mogu pojačati i/ili produljiti hipoglikemijski učinak repaglinida: gemfibrozil, klaritromicin, itrakonazol, ketokonazol, trimetoprim, ciklosporin, deferasiroks, klopidogrel, drugi antidijabetici, inhibitori monoamino oksidaze (MAO inhibitori), neselektivni beta-blokatori, inhibitori angiotenzin konvertirajućeg enzima (ACE inhibitori), salicilati, NSAIL, oktreotid, alkohol i anabolički steroidi.
However, the benefit risk profile remains to be established when comparing to other combination therapies.
Međutim, nije utvrđen omjer koristi i rizika u usporedbi s drugim kombiniranim terapijama.
• Nonsteroidal anti-inflammatory drugs (NSAID) (a type of painkillers).
- Nesteroidne protuupalne lijekove (NSAIL) (vrsta lijekova protiv bolova).
Consequently metabolism, and by that clearance of repaglinide, may be altered by substances which influence these cytochrome P-450 enzymes via inhibition or induction.
Posljedično tome metabolizam, a time i klirens repaglinida, može biti izmijenjen tvarima koje inhibiraju ili induciraju enzime citokroma P-450.
The starting dose of repaglinide is 0.5 mg, taken before main meals; titration is according to blood glucose response as for monotherapy.
Početna doza repaglinida je 0,5 mg prije glavnih obroka; titriranje doze ovisi o razini glukoze u krvi kao i kod monoterapije.
Special care should be taken when inhibitors of both CYP2C8 and 3A4 are coadministered simultaneously with repaglinide.
Poseban oprez potreban je u slučajevima kad se inhibitori oba enzima CYP2C8 i 3A4 primjenjuju istodobno s repaglinidom.
The concomitant use of gemfibrozil and repaglinide is contraindicated (see section 4.3).
Istodobna je primjena gemfibrozila i repaglinida kontraindicirana (vidjeti dio 4.3).
Enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose).
Enyglid je oralni antidijabetik (lijek protiv šećerne bolesti za primjenu kroz usta), a sadrži repaglinid koji pomaže gušterači da stvori više inzulina te tako snižava šećer (glukozu) u krvi.
Please see If you get a hypo on what a hypo is and how to treat it.
Pogledajte dio Ako dobijete hipoglikemiju kako biste znali što je hipoglikemija i kako se liječi.